Leuprolide (Lupron): What It Does and Its Risks
Also known as:
often mentioned with:
community guides:
Anonymous user report. Not medical advice. Peptides discussed are not FDA-approved for the uses described. Editorial process →
What is leuprolide?
Leuprolide (leuprorelin) is a synthetic nine-amino-acid analogue of gonadotropin-releasing hormone (GnRH), given by injection or long-acting depot as Lupron Depot, Eligard and generics. After a brief initial surge, continuous use shuts down the pituitary's LH and FSH signals, sharply lowering testosterone or estrogen.
FDA-approved uses include advanced prostate cancer, endometriosis, anemia from uterine fibroids before surgery, and central precocious puberty in children. It is the opposite of the testosterone-boosting peptides discussed elsewhere on this site (gonadorelin, kisspeptin).
What the labels warn
In prostate cancer, testosterone rises about 50% in the first weeks ("tumour flare"), which can temporarily worsen bone pain or urinary symptoms. Long-term hormone suppression causes hot flashes, loss of bone density, and metabolic and cardiovascular risks. For endometriosis, total treatment is limited to 12 months with add-back hormone therapy to protect bone. Last reviewed: October 2026.
Anonymous leuprolide reports
No reports found.
If you have used leuprolide, submit what happened.
Submit yoursCommunity Q&A
- What is leuprolide used for?
- Advanced prostate cancer, endometriosis, anemia from fibroids before surgery, and central precocious puberty, all under specialist care.
- Does Lupron lower testosterone?
- Yes. After an initial surge, continuous use suppresses testosterone to castration levels, which is the goal in prostate cancer.
- Does leuprolide affect bone density?
- Yes. Long-term hormone suppression lowers bone density, which is why some uses have time limits or add-back therapy.
Anonymous first-hand reports plus sourced context — educational only, not medical advice. Editorial policy & corrections.